Healthcare provider profile · identity verified

Patrick A Mcdougal

Nurse Practitioner · FLORENCE, SC · NPI 1275036618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	155
Amlodipine Besylate	Amlodipine Besylate	313	92
Losartan Potassium	Losartan Potassium	263	77
Albuterol Sulfate Hfa	Albuterol Sulfate	225	85
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	210	77
Fluticasone Propionate	Fluticasone Propionate	196	65
Gabapentin	Gabapentin	188	64
Fluconazole	Fluconazole	183	84
Omeprazole	Omeprazole	179	53
Pantoprazole Sodium	Pantoprazole Sodium	178	55
Metformin Hcl	Metformin Hcl	164	50
Pravastatin Sodium	Pravastatin Sodium	162	47
Prednisone	Prednisone	159	91
Hydrochlorothiazide	Hydrochlorothiazide	147	42
Jardiance	Empagliflozin	146	45
Lisinopril	Lisinopril	146	40
Ibu	Ibuprofen	145	59
Levothyroxine Sodium	Levothyroxine Sodium	139	38
Metoprolol Succinate	Metoprolol Succinate	130	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	122	41
Fenofibrate	Fenofibrate Nanocrystallized	122	37
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	120	75
Furosemide	Furosemide	118	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	116	31
Farxiga	Dapagliflozin Propanediol	107	33
Montelukast Sodium	Montelukast Sodium	98	26
Januvia	Sitagliptin Phosphate	89	24
Hydralazine Hcl	Hydralazine Hcl	86	26
Metoprolol Tartrate	Metoprolol Tartrate	85	26
Ozempic	Semaglutide	84	21
Janumet	Sitagliptin Phos/Metformin Hcl	81	24
Allopurinol	Allopurinol	80	26
Clonidine Hcl	Clonidine Hcl	79	23
Azithromycin	Azithromycin	74	45
Famotidine	Famotidine	71	24
Simvastatin	Simvastatin	71	19
Tamsulosin Hcl	Tamsulosin Hcl	71	23
Janumet Xr	Sitagliptin Phos/Metformin Hcl	69	22
Carvedilol	Carvedilol	66	20
Hydroxyzine Hcl	Hydroxyzine Hcl	64	22
Diclofenac Sodium	Diclofenac Sodium	62	29
Triamcinolone Acetonide	Triamcinolone Acetonide	61	29
Ondansetron Odt	Ondansetron	59	26
Meloxicam	Meloxicam	58	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	25
Ibuprofen	Ibuprofen	51	23
Klor-Con M20	Potassium Chloride	51	15
Clopidogrel	Clopidogrel Bisulfate	47	15
Ezetimibe	Ezetimibe	46	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	19
Levetiracetam	Levetiracetam	46	11
Esomeprazole Magnesium	Esomeprazole Magnesium	45	12
Meclizine Hcl	Meclizine Hcl	44	15
Lorazepam	Lorazepam	39	suppressed
Humalog Kwikpen U-100	Insulin Lispro	38	18
Rosuvastatin Calcium	Rosuvastatin Calcium	37	12
Atenolol	Atenolol	36	suppressed
Linzess	Linaclotide	36	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	35	17
Tizanidine Hcl	Tizanidine Hcl	34	11
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Eliquis	Apixaban	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	30	13
Cephalexin	Cephalexin	29	24
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	24
Sertraline Hcl	Sertraline Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	25	13
Glipizide Er	Glipizide	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Finasteride	Finasteride	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Gemtesa	Vibegron	23	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Valsartan	Valsartan	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Glipizide	Glipizide	21	suppressed
Risperidone	Risperidone	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Colchicine	Colchicine	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Methimazole	Methimazole	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Nystatin	Nystatin	15	suppressed
Bumetanide	Bumetanide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error